Key Considerations for Advanced Therapies Manufacturing

Description

Speaker: Dr. Thomas Page, PhD, Vice-President, Engineering and Asset Development, FUJIFILM Diosynth Biotechnologies

This technical seminar will go over key considerations to support manufacturing activities from the earliest stages of cell line, viral replication platforms and/or viral vectors identification stage leading into clinical production. Having a line of sight into commercial production and the requirements leading into commercial approval are also essential for success.

Some key messages will include:
• Flexibility in conjunction with high containment are key for success
• Application of closed systems in designing the manufacturing process including Fill/Finish
• Facilities to support Advanced therapy manufacturing should be treated as pieces of equipment

A light lunch will be served.